摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3S,4S)-3-hexyl-4-((R)-2-hydroxytridec-5-enyl)-oxetan-2-one

中文名称
——
中文别名
——
英文名称
(3S,4S)-3-hexyl-4-((R)-2-hydroxytridec-5-enyl)-oxetan-2-one
英文别名
(2R,3S,4S)-3-hexyl-4-(2-hydroxy-tridec-5-enyl)-oxetan-2-one;(3S,4S)-3-hexyl-4-[(2R)-2-hydroxytridec-5-enyl]oxetan-2-one
(3S,4S)-3-hexyl-4-((R)-2-hydroxytridec-5-enyl)-oxetan-2-one化学式
CAS
——
化学式
C22H40O3
mdl
——
分子量
352.558
InChiKey
FRSRRPYDOYLOGF-HKBOAZHASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.6
  • 重原子数:
    25
  • 可旋转键数:
    16
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (3S,4S)-3-hexyl-4-((R)-2-hydroxytridec-5-enyl)-oxetan-2-one 在 palladium on activated charcoal 偶氮二甲酸二异丙酯氢气三苯基膦 作用下, 以 四氢呋喃 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 12.0h, 生成 奥利司他
    参考文献:
    名称:
    Total Synthesis and Comparative Analysis of Orlistat, Valilactone, and a Transposed Orlistat Derivative:  Inhibitors of Fatty Acid Synthase
    摘要:
    Concise syntheses of orlistat ( Xenical), a two-carbon transposed orlistat derivative, and valilactone are described that employ the tandem Mukaiyama aldol-lactonization (TMAL) process as a key step. This process allows facile modification of the alpha-side chain. Versatile strategies for modifying the delta-side chain are described, involving cuprate addition and olefin metathesis. Comparative antagonistic activity of these derivatives toward a recombinant form of the thioesterase domain of fatty acid synthase is reported along with comparative activity-based profiling.
    DOI:
    10.1021/ol061651o
点击查看最新优质反应信息

文献信息

  • BETA-LACTONE COMPOUNDS
    申请人:Smith Jeffrey W.
    公开号:US20090124681A1
    公开(公告)日:2009-05-14
    The present invention provides compounds having the general structure A, or a pharmaceutically acceptable derivatives thereof: wherein R is an alkyl group, and R 1 comprises at least one moiety selected from a group consisting of an alkyl, an alkenyl, an aryl, a heterocycle, hydroxyl, ester, amido, aldehyde, and a halogen.
    本发明提供具有一般结构A的化合物,或其药学上可接受的衍生物:其中R是烷基基团,R1包括至少一种从烷基、烯基、芳基、杂环、羟基、酯、酰胺、醛基和卤素组成的基团。
  • Total Synthesis and Comparative Analysis of Orlistat, Valilactone, and a Transposed Orlistat Derivative:  Inhibitors of Fatty Acid Synthase
    作者:Gil Ma、Manuel Zancanella、Yatsandra Oyola、Robyn D. Richardson、Jeffrey W. Smith、Daniel Romo
    DOI:10.1021/ol061651o
    日期:2006.9.1
    Concise syntheses of orlistat ( Xenical), a two-carbon transposed orlistat derivative, and valilactone are described that employ the tandem Mukaiyama aldol-lactonization (TMAL) process as a key step. This process allows facile modification of the alpha-side chain. Versatile strategies for modifying the delta-side chain are described, involving cuprate addition and olefin metathesis. Comparative antagonistic activity of these derivatives toward a recombinant form of the thioesterase domain of fatty acid synthase is reported along with comparative activity-based profiling.
查看更多